Naresh Tanna
Chief Financial OfficerMr. Naresh Tanna is Chief Financial Officer of Precision BioSciences, Inc. since August 1, 2026. He was Chief of Staff to CEO & Vice President of Investor Relations of Precision BioSciences, Inc. from October 2024 until August 1, 2026. Mr. Tanna served as a Global Oncology Marketing Director at Amgen Inc. from January 2020 until joining Precision BioSciences, Inc. in January 2022. In addition, Mr. Tanna brings over 20 years of diverse experiences across oncology, infectious diseases and rare diseases across treatment modalities, having held leadership roles in global oncology marketing and financial planning and analysis at Amgen Inc., AbbVie Inc., Celgene Corporation and Eli Lilly and Company focusing on marketing, strategy and execution across commercial and development stage products. Earlier in his career, Mr. Tanna held life sciences consulting roles at Trinity Partners and Clarkston Consulting. Mr. Tanna holds a Master of Business Administration from the IESE Business School and a Bachelor of Science in Biomedical Engineering and Political Science from Rutgers School of Engineering and has earned a Chief Financial Officer certificate from the executive program at The Wharton School of the University of Pennsylvania.
Positions
- Company NamePrecision BioSciences, Inc.Stock CodeDTILPositionChief Financial OfficerColleagues
- MAMichael AmorosoPresident, CEO & Director
- KJKevin J. BuehlerIndependent Chairman
- JAJohn Alexander KellyChief Operating Officer
- DSDario ScimecaChief Legal Officer & Secretary
- JJJefferson J. SmithCo-Founder & Chief Research Officer
- GJGeno J. GermanoIndependent Director
- SLShari Lisa PireIndependent Director
- MBMelinda BrownIndependent Director
